Skip to content

Genetic Origin of Lipid Disorders

Genetic Origin of Lipid Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00277121
Enrollment
Unknown
Registered
2006-01-13
Start date
2006-01-31
Completion date
Unknown
Last updated
2006-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipid Disorder

Keywords

Lipid disorder, Gene mutation

Brief summary

Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. The resulting mutations will be tested in suitable in vitro systems to detect their part in development of the specific disease.

Detailed description

See brief summary above.

Interventions

None listed

Sponsors

Lipid Clinic, The National Hospital, Oslo, Norway
CollaboratorUNKNOWN
Research Institute of Internal Medicine, The National Hospital, Oslo, Norway
CollaboratorUNKNOWN
Ullevaal University Hospital
CollaboratorOTHER
Norwegian Institute of Public Health
CollaboratorOTHER_GOV
Hormone Laboratory, Aker University Hospital, Oslo, Norway
CollaboratorOTHER
CIGENE, Agricultural University of Norway, Aas, Norway
CollaboratorOTHER
University of Oslo
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 54 Years
Healthy volunteers
Yes

Inclusion criteria

* proven written informed consent prior to recruitment * male or female * 18-55 years old * patients with severe lipid disorders * fasting plasma cholesterol, triglyceride or glucose, blood pressure or waist circumference/BMI out of normal range

Exclusion criteria

\-

Countries

Norway

Contacts

Primary ContactHilde Irene Nebb, PhD
h.i.nebb@medisin.uio.no+47-22851510
Backup ContactKjetil Retterstøl, Dr Med
kjetil.retterstol@rikshospitalet.no+47-23075603

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026